These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 34107897)
1. Prevalence of increased transaminases and its association with sex, age, and metabolic parameters in children and adolescents with obesity - a nationwide cross-sectional cohort study. Putri RR; Casswall T; Hagman E BMC Pediatr; 2021 Jun; 21(1):271. PubMed ID: 34107897 [TBL] [Abstract][Full Text] [Related]
2. Modifiable clinical and lifestyle factors are associated with elevated alanine aminotransferase levels in newly diagnosed type 2 diabetes patients: results from the nationwide DD2 study. Mor A; Svensson E; Rungby J; Ulrichsen SP; Berencsi K; Nielsen JS; Stidsen JV; Friborg S; Brandslund I; Christiansen JS; Beck-Nielsen H; Sørensen HT; Thomsen RW Diabetes Metab Res Rev; 2014 Nov; 30(8):707-15. PubMed ID: 24639417 [TBL] [Abstract][Full Text] [Related]
3. Increased liver echogenicity and liver enzymes are associated with extreme obesity, adolescent age and male gender: analysis from the German/Austrian/Swiss obesity registry APV. Greber-Platzer S; Thajer A; Bohn S; Brunert A; Boerner F; Siegfried W; Artlich A; Moeckel A; Waldecker-Krebs H; Pauer S; Holl RW; BMC Pediatr; 2019 Sep; 19(1):332. PubMed ID: 31514755 [TBL] [Abstract][Full Text] [Related]
4. Prevalence and risk factors of elevated alanine aminotransferase among Korean adolescents: 2001-2014. Kim JW; Lee KJ; Yang HR; Chang JY; Moon JS; Khang YH; Ko JS BMC Public Health; 2018 May; 18(1):617. PubMed ID: 29751750 [TBL] [Abstract][Full Text] [Related]
5. Stratification by obesity class, rather than age, can identify a higher percent of children at risk for non-alcoholic fatty liver disease and metabolic dysfunction. Radulescu A; Dugan AJ; Killian M; Attia SL; Mouzaki M; Fuchs GJ; Kohli R; Bada H; Kern PA; Softic S Pediatr Obes; 2022 Mar; 17(3):e12862. PubMed ID: 34662928 [TBL] [Abstract][Full Text] [Related]
6. Normal serum alanine aminotransferase and non-alcoholic fatty liver disease among Korean adolescents: a cross-sectional study using data from KNHANES 2010-2015. Kang Y; Park S; Kim S; Koh H BMC Pediatr; 2018 Jul; 18(1):215. PubMed ID: 29976192 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors for non-alcoholic fatty liver in children and youth with obesity. Jimenez-Rivera C; Hadjiyannakis S; Davila J; Hurteau J; Aglipay M; Barrowman N; Adamo KB BMC Pediatr; 2017 Apr; 17(1):113. PubMed ID: 28446162 [TBL] [Abstract][Full Text] [Related]
8. Gender-specific differences in clinical and metabolic variables associated with NAFLD in a Mexican pediatric population. Villanueva-Ortega E; Garcés-Hernández MJ; Herrera-Rosas A; López-Alvarenga JC; Laresgoiti-Servitje E; Escobedo G; Queipo G; Cuevas-Covarrubias S; Garibay-Nieto GN Ann Hepatol; 2019; 18(5):693-700. PubMed ID: 31151875 [TBL] [Abstract][Full Text] [Related]
9. Alanine aminotransferase cutoffs for the pediatric fatty liver disease: Major impact of the reference population. Aitokari L; Lahti S; Kivelä L; Riekki H; Hiltunen P; Vuorela N; Viitasalo A; Soininen S; Huhtala H; Lakka T; Kurppa K J Pediatr Gastroenterol Nutr; 2024 Mar; 78(3):488-496. PubMed ID: 38314943 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of Elevated ALT in Adolescents in the US 2011-2018. Mischel AK; Liao Z; Cao F; Dunn W; Lo JC; Newton KP; Goyal NP; Yu EL; Schwimmer JB J Pediatr Gastroenterol Nutr; 2023 Jul; 77(1):103-109. PubMed ID: 37084344 [TBL] [Abstract][Full Text] [Related]
11. Influence of light alcohol consumption on lifestyle-related diseases: a predictor of fatty liver with liver enzyme elevation in Japanese females with metabolic syndrome. Sogabe M; Okahisa T; Nakagawa T; Fukuno H; Nakasono M; Tomonari T; Tanaka T; Tanaka H; Taniguchi T; Muguruma N; Takayama T BMC Gastroenterol; 2016 Feb; 16():17. PubMed ID: 26892109 [TBL] [Abstract][Full Text] [Related]
13. Factors associated with elevated alanine aminotransferase in employees of a German chemical company: results of a large cross-sectional study. Claus M; Antoni C; Hofmann B BMC Gastroenterol; 2021 Jan; 21(1):25. PubMed ID: 33422007 [TBL] [Abstract][Full Text] [Related]
14. Ethnic and sex differences in the association between metabolic syndrome and suspected nonalcoholic fatty liver disease in a nationally representative sample of US adolescents. Graham RC; Burke A; Stettler N J Pediatr Gastroenterol Nutr; 2009 Oct; 49(4):442-9. PubMed ID: 19644391 [TBL] [Abstract][Full Text] [Related]
15. Moderation Effect of Handgrip Strength on the Associations of Obesity and Metabolic Syndrome With Fatty Liver in Adolescents. Lee K J Clin Densitom; 2020; 23(2):278-285. PubMed ID: 31060787 [TBL] [Abstract][Full Text] [Related]
16. Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity. Mohamed RZ; Jalaludin MY; Anuar Zaini A J Pediatr Endocrinol Metab; 2020 Feb; 33(2):247-253. PubMed ID: 31926095 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in European German-speaking countries. Analysis of the APV initiative. Koutny F; Weghuber D; Bollow E; Greber-Platzer S; Hartmann K; Körner A; Reinehr T; Roebl M; Simic-Schleicher G; Wabitsch M; Widhalm K; Wiegand S; Holl RW Pediatr Obes; 2020 Apr; 15(4):e12601. PubMed ID: 31810110 [TBL] [Abstract][Full Text] [Related]
18. [Detecting non-alcoholic fatty liver in children with owerweight and obesity.]. García-López NA; Jiménez-Álvarez A; Murillo-Zamora E Rev Med Inst Mex Seguro Soc; 2021 Nov; 59(6):465-472. PubMed ID: 34905320 [TBL] [Abstract][Full Text] [Related]
19. Prevalence and associated metabolic factors of fatty liver disease in the elderly. Wang Z; Xu M; Peng J; Jiang L; Hu Z; Wang H; Zhou S; Zhou R; Hultström M; Lai EY Exp Gerontol; 2013 Aug; 48(8):705-9. PubMed ID: 23721951 [TBL] [Abstract][Full Text] [Related]
20. Prevalence and associated factors of metabolic-associated fatty liver disease in overweight Finnish children and adolescents. Riekki H; Aitokari L; Kivelä L; Lahti S; Hiltunen P; Vuorela N; Huhtala H; Lakka TA; Kurppa K Front Endocrinol (Lausanne); 2023; 14():1090344. PubMed ID: 37409224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]